scPharmaceuticals Inc. — Form D
scPharmaceuticals Inc. of Lexington, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-01-06. The offering totals $47.0M, of which $47.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-01-06
- Form: D
- Accession: 0001604950-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $47.0M
- Amount sold: $47.0M
- Investors: 11
- Date of first sale: 2016-12-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-277857
Issuer
- Name: scPharmaceuticals Inc.
- CIK: 0001604950
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 131 Hartwell Avenue, Lexington, MA, 02421
- Phone: 617-517-0730
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Mette Agger | Director | Lexington, MA |
| Dorothy Coleman | Director | Lexington, MA |
| Abhay Gandhi | Director | Lexington, MA |
| Jack Khattar | Director | Lexington, MA |
| Pieter Muntendam | Director | Lexington, MA |
| Kush Parmar | Director | San Francisco, CA |
| Leonard Schaeffer | Director | Lexington, MA |
| Jonathan Silverstein | Director | Chicago, IL |
| Abraham Ceesay | Executive Officer | Lexington, MA |
| Troy Ignelzi | Executive Officer | Cambridge, MA |
| Pieter Muntendam | Executive Officer | Lexington, MA |
| Mette Kirstine Agger | Director | CAMBRIDGE, MA |
| Dorothy Kirstine Coleman | Director | Lexington, MA |
| Leonard Kirstine Schaeffer | Director | Lexington, MA |
Other filings by this issuer (4)
More